We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$9.7B
AUM Growth
-$152M
Cap. Flow
+$293M
Cap. Flow %
3.03%
Top 10 Hldgs %
29.73%
Holding
234
New
14
Increased
60
Reduced
64
Closed
43

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$74.9M
2
ABT icon
Abbott
ABT
+$45.9M
3
MOH icon
Molina Healthcare
MOH
+$43.5M
4
DHR icon
Danaher
DHR
+$42M
5
MDT icon
Medtronic
MDT
+$38M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$63.1M
2
BAX icon
Baxter International
BAX
+$38.1M
3
CNC icon
Centene
CNC
+$36.2M
4
HOLX
Hologic
HOLX
+$21.4M
5
DXCM icon
DexCom
DXCM
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.85%
2 Technology 0.8%
3 Industrials 0.75%
4 Communication Services 0.02%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
176
American Express
AXP
$223B
$245K ﹤0.01%
1,500
-1,100
-42% -$188K
MELI icon
177
Mercado Libre
MELI
$91.3B
$229K ﹤0.01%
170
– –
OLED icon
178
Universal Display
OLED
$3.71B
$225K ﹤0.01%
1,365
– –
CLX icon
179
Clorox
CLX
$11.6B
$209K ﹤0.01%
1,200
-800
-40% -$133K
JMIA
180
Jumia Technologies
JMIA
$726M
$205K ﹤0.01%
18,000
– –
IPGP icon
181
IPG Photonics
IPGP
$3.89B
$181K ﹤0.01%
1,050
-300
-22% -$49.6K
AVLR
182
DELISTED
Avalara, Inc.
AVLR
$168K ﹤0.01%
1,300
-1,000
-43% -$156K
A icon
183
Agilent Technologies
A
$39.1B
$160K ﹤0.01%
1,000
-1,700
-63% -$265K
STNE icon
184
StoneCo
STNE
$2.62B
$72K ﹤0.01%
4,300
– –
TSM icon
185
TSMC
TSM
$2.09T
$42K ﹤0.01%
+346
New +$40.5K
EVTC icon
186
Evertec
EVTC
$1.83B
$37K ﹤0.01%
+739
New +$34.2K
EQIX icon
187
Equinix
EQIX
$107B
$34K ﹤0.01%
+40
New +$32.1K
UMC icon
188
United Microelectronic
UMC
$48.9B
$32K ﹤0.01%
+2,698
New +$30K
INFY icon
189
Infosys
INFY
$45B
$29K ﹤0.01%
+1,130
New +$26.3K
ASR icon
190
Grupo Aeroportuario del Sureste
ASR
$8.03B
$28K ﹤0.01%
+135
New +$26.6K
NIO icon
191
NIO
NIO
$11.3B
$25K ﹤0.01%
+780
New +$28.7K
ACIU icon
192
AC Immune
ACIU
$227M
– –
-139,000
Closed -$933K
ALLK
193
DELISTED
Allakos
ALLK
– –
-18,500
Closed -$1.96M
ANSS
194
DELISTED
Ansys
ANSS
– –
-900
Closed -$306K
BF.B icon
195
Brown-Forman Class B
BF.B
$12B
– –
-4,600
Closed -$308K
BKNG icon
196
Booking.com
BKNG
$138B
– –
-4,000
Closed -$380K
CSGP icon
197
CoStar Group
CSGP
$11.3B
– –
-3,500
Closed -$301K
CVAC
198
CALL
DELISTED
CureVac
CVAC
– –
-120
Closed -$1K
CVAC
199
DELISTED
CureVac
CVAC
– –
-35,200
Closed -$1.92M
DPZ icon
200
Domino's
DPZ
$11B
– –
-1,000
Closed -$477K
6 7
8
9 10

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q4 2021 Portfolio in Review

As of Q4 2021, Bellevue Group held 234 positions worth $9.7B, down 1.5% from $9.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bellevue Group deployed $293M of net new capital in Q4 2021, opening 14 new positions and adding to 60 existing holdings. Its largest new stake was AstraZeneca: 29,500 shares worth $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Baxter International, an estimated $38.1M trimmed.

  • Bellevue Group's largest Q4 2021 buy was AstraZeneca: 29,500 shares worth $3.44M.
  • Bellevue Group added most to CareDx in Q4 2021, an estimated $74.9M increase.
  • Bellevue Group's biggest Q4 2021 reduction was Baxter International, cutting an estimated $38.1M.
  • Bellevue Group fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $63.1M.
  • Bellevue Group's ten largest holdings make up 30% of its $9.7B portfolio in Q4 2021.
  • Bellevue Group opened 14 new positions and closed 43 in Q4 2021.
  • Bellevue Group's portfolio value fell 1.5% quarter-over-quarter to $9.7B.

Based on Bellevue Group's 13F filing for Q4 2021, filed 10 Feb 2022.